Cargando…

Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes

OBJECTIVE: Data on cardiac function in patients with nonalcoholic fatty liver disease (NAFLD) are limited and conflicting. We assessed whether NAFLD is associated with abnormalities in cardiac function in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: We studied 50 consecutive type 2 di...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonapace, Stefano, Perseghin, Gianluca, Molon, Giulio, Canali, Guido, Bertolini, Lorenzo, Zoppini, Giacomo, Barbieri, Enrico, Targher, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263884/
https://www.ncbi.nlm.nih.gov/pubmed/22210573
http://dx.doi.org/10.2337/dc11-1820
_version_ 1782221943246684160
author Bonapace, Stefano
Perseghin, Gianluca
Molon, Giulio
Canali, Guido
Bertolini, Lorenzo
Zoppini, Giacomo
Barbieri, Enrico
Targher, Giovanni
author_facet Bonapace, Stefano
Perseghin, Gianluca
Molon, Giulio
Canali, Guido
Bertolini, Lorenzo
Zoppini, Giacomo
Barbieri, Enrico
Targher, Giovanni
author_sort Bonapace, Stefano
collection PubMed
description OBJECTIVE: Data on cardiac function in patients with nonalcoholic fatty liver disease (NAFLD) are limited and conflicting. We assessed whether NAFLD is associated with abnormalities in cardiac function in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: We studied 50 consecutive type 2 diabetic individuals without a history of ischemic heart disease, hepatic diseases, or excessive alcohol consumption, in whom NAFLD was diagnosed by ultrasonography. A tissue Doppler echocardiography with myocardial strain measurement was performed in all patients. RESULTS: Thirty-two patients (64%) had NAFLD, and when compared with the other 18 patients, age, sex, BMI, waist circumference, hypertension, smoking, diabetes duration, microvascular complication status, and medication use were not significantly different. In addition, the left ventricular (LV) mass and volumes, ejection fraction, systemic vascular resistance, arterial elasticity, and compliance were also not different. NAFLD patients had lower e′ (8.2 ± 1.5 vs. 9.9 ± 1.9 cm/s, P < 0.005) tissue velocity, higher E-to-e′ ratio (7.90 ± 1.3 vs. 5.59 ± 1.1, P < 0.0001), a higher time constant of isovolumic relaxation (43.1 ± 10.1 vs. 33.2 ± 12.9 ms, P < 0.01), higher LV–end diastolic pressure (EDP) (16.5 ± 1.1 vs. 15.1 ± 1.0 mmHg, P < 0.0001), and higher LV EDP/end diastolic volume (0.20 ± 0.03 vs. 0.18 ± 0.02 mmHg, P < 0.05) than those without steatosis. Among the measurements of LV global longitudinal strain and strain rate, those with NAFLD also had higher E/global longitudinal diastolic strain rate during the early phase of diastole (E/SR(E)). All of these differences remained significant after adjustment for hypertension and other cardiometabolic risk factors. CONCLUSIONS: Our data show that in patients with type 2 diabetes and NAFLD, even if the LV morphology and systolic function are preserved, early features of LV diastolic dysfunction may be detected.
format Online
Article
Text
id pubmed-3263884
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-32638842013-02-01 Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes Bonapace, Stefano Perseghin, Gianluca Molon, Giulio Canali, Guido Bertolini, Lorenzo Zoppini, Giacomo Barbieri, Enrico Targher, Giovanni Diabetes Care Original Research OBJECTIVE: Data on cardiac function in patients with nonalcoholic fatty liver disease (NAFLD) are limited and conflicting. We assessed whether NAFLD is associated with abnormalities in cardiac function in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: We studied 50 consecutive type 2 diabetic individuals without a history of ischemic heart disease, hepatic diseases, or excessive alcohol consumption, in whom NAFLD was diagnosed by ultrasonography. A tissue Doppler echocardiography with myocardial strain measurement was performed in all patients. RESULTS: Thirty-two patients (64%) had NAFLD, and when compared with the other 18 patients, age, sex, BMI, waist circumference, hypertension, smoking, diabetes duration, microvascular complication status, and medication use were not significantly different. In addition, the left ventricular (LV) mass and volumes, ejection fraction, systemic vascular resistance, arterial elasticity, and compliance were also not different. NAFLD patients had lower e′ (8.2 ± 1.5 vs. 9.9 ± 1.9 cm/s, P < 0.005) tissue velocity, higher E-to-e′ ratio (7.90 ± 1.3 vs. 5.59 ± 1.1, P < 0.0001), a higher time constant of isovolumic relaxation (43.1 ± 10.1 vs. 33.2 ± 12.9 ms, P < 0.01), higher LV–end diastolic pressure (EDP) (16.5 ± 1.1 vs. 15.1 ± 1.0 mmHg, P < 0.0001), and higher LV EDP/end diastolic volume (0.20 ± 0.03 vs. 0.18 ± 0.02 mmHg, P < 0.05) than those without steatosis. Among the measurements of LV global longitudinal strain and strain rate, those with NAFLD also had higher E/global longitudinal diastolic strain rate during the early phase of diastole (E/SR(E)). All of these differences remained significant after adjustment for hypertension and other cardiometabolic risk factors. CONCLUSIONS: Our data show that in patients with type 2 diabetes and NAFLD, even if the LV morphology and systolic function are preserved, early features of LV diastolic dysfunction may be detected. American Diabetes Association 2012-02 2012-01-16 /pmc/articles/PMC3263884/ /pubmed/22210573 http://dx.doi.org/10.2337/dc11-1820 Text en © 2012 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Original Research
Bonapace, Stefano
Perseghin, Gianluca
Molon, Giulio
Canali, Guido
Bertolini, Lorenzo
Zoppini, Giacomo
Barbieri, Enrico
Targher, Giovanni
Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes
title Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes
title_full Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes
title_fullStr Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes
title_full_unstemmed Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes
title_short Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes
title_sort nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263884/
https://www.ncbi.nlm.nih.gov/pubmed/22210573
http://dx.doi.org/10.2337/dc11-1820
work_keys_str_mv AT bonapacestefano nonalcoholicfattyliverdiseaseisassociatedwithleftventriculardiastolicdysfunctioninpatientswithtype2diabetes
AT perseghingianluca nonalcoholicfattyliverdiseaseisassociatedwithleftventriculardiastolicdysfunctioninpatientswithtype2diabetes
AT molongiulio nonalcoholicfattyliverdiseaseisassociatedwithleftventriculardiastolicdysfunctioninpatientswithtype2diabetes
AT canaliguido nonalcoholicfattyliverdiseaseisassociatedwithleftventriculardiastolicdysfunctioninpatientswithtype2diabetes
AT bertolinilorenzo nonalcoholicfattyliverdiseaseisassociatedwithleftventriculardiastolicdysfunctioninpatientswithtype2diabetes
AT zoppinigiacomo nonalcoholicfattyliverdiseaseisassociatedwithleftventriculardiastolicdysfunctioninpatientswithtype2diabetes
AT barbierienrico nonalcoholicfattyliverdiseaseisassociatedwithleftventriculardiastolicdysfunctioninpatientswithtype2diabetes
AT targhergiovanni nonalcoholicfattyliverdiseaseisassociatedwithleftventriculardiastolicdysfunctioninpatientswithtype2diabetes